Latin America Continuous Glucose Monitoring Device Market

Latin America Continuous Glucose Monitoring
Device Market Trends And Outlook 2018-2026
Continuous glucose monitoring devices have the potential to improve clinical outcomes for
avoiding hypo/hyperglycemic events, an outcome of uncontrolled diabetes, which can arise due
to skipped insulin dose. The currently available CGM devices display the glucose level and the
magnitude and direction of changing glucose levels, thus becoming a vital tool to predict the
forthcoming events of hypo- and hyperglycemia. Moreover, the device is more convenient for
type 1 diabetic patients, as it requires continuous monitoring of glucose for administration of
insulin on regular basis. Thus, use and benefits of CGM device in controlling both type 1
diabetes and hypoglycemia & hyperglycemia is expected to drive the market growth.
Request PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2993
The Latin America continuous glucose monitoring device market was valued at US$ 126.2
million in 2018 and is expected to witness a CAGR of 15.9% during the forecast period (2018–
2026).
Increasing initiative by key players for distribution of continuous monitoring device in Latin
America is expected to boost growth of Latin America continuous glucose monitoring device
market
Major players are adopting inorganic growth strategies such as collaboration, in order to
distribute their products in Latin America and increase their market share in the region. For
instance, in February 2019, Senseonics Holdings, Inc. announced expansion of distribution
agreement with Roche Diabetes Care by providing them with exclusive distribution rights, for
distribution of implantable continuous glucose monitoring (CGM) system, in 17 countries
including Brazil, Russia, India, and China as well as selected markets in the Asia Pacific and
Latin American regions.
Moreover, increasing product launches by key players also contribute to growth of Latin
America continuous glucose monitoring device market. Insulin pumps segment is expected to
witness significant growth over the forecast period, owing to increasing product launches of
insulin pumps for continuous glucose monitoring. For instance, in March 2019, Medtronic Plc.
launched MiniMed 670G system, a self-adjusting insulin pump system for patients who have
type 1 diabetes, in the U.K. Medtronic Plc. also supplies diabetic care products in Latin
American countries such as Brazil, Chile, Colombia, and others.
Report includes chapters which deeply display the following deliverable about industry :
• Latin America Continuous Glucose Monitoring Device Market Research Objective and
Assumption
• Latin America Continuous Glucose Monitoring Device Market Purview - Report Description,
Executive Summary, and Coherent Opportunity Map (COM)
• Latin America Continuous Glucose Monitoring Device Market Dynamics, Regulations, and
Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and
Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST
Analysis
• Global Latin America Continuous Glucose Monitoring Device Market, By Regions
• Latin America Continuous Glucose Monitoring Device Market Competition by Manufacturers
including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales
Area and Product Type.
• Latin America Continuous Glucose Monitoring Device Market Manufacturers Profiles/Analysis
including Company Basic Information, Manufacturing Base and Its Competitors.
• Latin America Continuous Glucose Monitoring Device Market Manufacturing Cost Analysis
including Key Raw Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Latin America Continuous Glucose Monitoring Device Market Forecast including Production,
Consumption, Import and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Market Dynamics
Latin America continuous glucose monitoring device market is expected to witness significant
growth over the forecast period, owing to increasing incidence of diabetes in Latin American
countries which may result in increasing demand for continuous glucose monitoring device in
this region. For instance, according to Global Burden of Disease Study 2016, the incidence rate
of diabetes in Latin America increased from 2.74% in 2010 to 3.06% in 2016. Among all
countries in Latin America, diabetes affects large number of adult population based in Mexico
and Brazil.
Latin America Continuous Glucose Monitoring Device Market- Competitive Landscape
Key players operating in Latin America continuous glucose monitoring device market include
Medtronic Plc, Abbott, F. Hoffmann-La Roche AG, Johnson & Johnson, Senseonics, Inc,
Dexcom, Inc., Insulet Corporation, and Tandem Diabetes Care, Inc.
For More Details On this Report: https://www.coherentmarketinsights.com/market-insight/latinamerica-continuous-glucose-monitoring-cgm-device-market-2993
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Continuous glucose monitoring devices are considered as significant systems for improving diabetes management by providing better and pain-free blood glucose measurement.

Download Report